QURT: Quarta-Rad, Inc. Stock

SIC 3823 – Industrial Instruments for Measurement, Display, and Control of Process Variables; and Related Products

Valuation
Market Cap ($M) 15.67
Enterprise Value ($M) 15.62
Book Value ($M) 0.24
Book Value / Share 0.02
Price / Book 66.14
NCAV ($M) -0.24
NCAV / Share -0.02
Price / NCAV -65.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.37
Return on Assets (ROA) -0.12
Return on Equity (ROE) -0.27

Liquidity (mrq)
Quick Ratio 0.37
Current Ratio 0.38

Balance Sheet (mrq) ($M)
Current Assets 0.15
Assets 0.62
Liabilities 0.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ quarterly REPORT under SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2024 ☐ TRANSITION REPORT UNDER SECTION
2024-08-16 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT under SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 ☐ TRANSITION REPORT UN
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ quarterly REPORT under SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 O
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ quarterly REPORT under SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT under SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15

(click for more detail)

Similar Companies
NINOF – Nikon Corporation OPST – OPT-Sciences Corporation
PBIO – Pressure BioSciences, Inc. RLBY – Reliability Incorporated
RSCF – Reflect Scientific, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.